Findings support use of the non-invasive platform for advanced infection care by enhancing antibiotic effectiveness against implant-associated biofilms.
The system is indicated for fusion of the sacroiliac joint for sacroiliac joint dysfunction including sacroiliac joint disruption and degenerative sacroiliitis.
The exclusive U.S. distribution agreement adds the A’TOMIC Nitinol Fixation System to the Smith+Nephew Trauma, Foot & Ankle and Hand & Wrist portfolio.